ANTIBODY FORMULATION IN HISTIDINE-ACETATE BUFFER

- Thepresent application describes antibody formulations, including monoclonalantibodies formulated in histidine-acetate buffer, as well as a formulationcomprising an antibody that binds to domain E of HER2 (for example,Pertuzumab), and a formulation comprising an antibody that binds to DRS(for exam...

Full description

Saved in:
Bibliographic Details
Main Authors LIU, JUN, GWEE, SHIANG, C, SHEN, YE, ANDYA, JAMES, D
Format Patent
LanguageEnglish
Published 13.02.2014
Online AccessGet full text

Cover

More Information
Summary:- Thepresent application describes antibody formulations, including monoclonalantibodies formulated in histidine-acetate buffer, as well as a formulationcomprising an antibody that binds to domain E of HER2 (for example,Pertuzumab), and a formulation comprising an antibody that binds to DRS(for example, Apomab). No figure to accompany Abstract
Bibliography:Application Number: SG20140005201